Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Mohammad S. Ghaemi, Adi L. Tarca, Roberto Romero, Natalie Stanley, Ramin Fallahzadeh, Athena Tanada, Anthony Culos, Kazuo Ando, Xiaoyuan Han, Yair J. Blumenfeld, Maurice L. Druzin, Yasser Y. El-Sayed, Ronald S. Gibbs, Virginia D. Winn, Kevin Contrepois, Xuefeng B. Ling, Ronald J. Wong, Gary M. Shaw, David K. Stevenson, Brice Gaudilliere, Nima Aghaeepour & Martin S. Angst. (2022) Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts – implications for clinical biomarker studies. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 5621-5628.
Read now
Read now
Rachel Gomez-Tolub, Anat Rabinovich, Eric Kachko, Neta Benshalom-Tirosh, Dan Tirosh, Jecko Thachil, Limor Besser, Nandor Gabor Than & Offer Erez. (2022) Placental abruption as a trigger of DIC in women with HELLP syndrome: a population-based study. The Journal of Maternal-Fetal & Neonatal Medicine 35:17, pages 3259-3269.
Read now
Read now
Nikolina Docheva, Roberto Romero, Piya Chaemsaithong, Adi L. Tarca, Gaurav Bhatti, Percy Pacora, Bogdan Panaitescu, Noppadol Chaiyasit, Tinnakorn Chaiworapongsa, Eli Maymon, Sonia S. Hassan & Offer Erez. (2019) The profiles of soluble adhesion molecules in the “great obstetrical syndromes”*. The Journal of Maternal-Fetal & Neonatal Medicine 32:13, pages 2113-2136.
Read now
Read now
Yasemin Çekmez, Şebnem Garip, İpek Ulu, Serdar Gülşen, Esra Tuştaş Haberal, Yusuf Olgac, Eser Evrim Yoğurtçuoğlu, Simge Bagcı Türkmen, Fatma Tutku Aksoy & Gürkan Kıran. (2017) Maternal serum Netrin-1 levels as a new biomarker of preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 30:9, pages 1072-1074.
Read now
Read now
Saira Salahuddin, Julia B. Wenger, Dongsheng Zhang, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2016) KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes. Hypertension in Pregnancy 35:3, pages 330-345.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Amy E. Whitten, Steven J. Korzeniewski, Piya Chaemsaithong, Edgar Hernandez-Andrade, Lami Yeo & Sonia S. Hassan. (2016) The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 29:8, pages 1214-1228.
Read now
Read now
Piya Chaemsaithong, Roberto Romero, Adi L. Tarca, Steven J. Korzeniewski, Alyse G. Schwartz, Jezid Miranda, Ahmed I. Ahmed, Zhong Dong, Sonia S. Hassan, Lami Yeo & Tinnakorn Tinnakorn. (2015) Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study. The Journal of Maternal-Fetal & Neonatal Medicine 28:11, pages 1260-1269.
Read now
Read now
Kedak Baltajian, Jonathan L. Hecht, Julia B. Wenger, Saira Salahuddin, Stefan Verlohren, Frank H. Perschel, Zsuzsanna K. Zsengeller, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2014) Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertension in Pregnancy 33:4, pages 427-439.
Read now
Read now
Articles from other publishers (54)
Tinnakorn Chaiworapongsa, Roberto Romero, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Stanley M. Berry, Awoniyi Awonuga, Adi L. Tarca & David R. Bryant. (2023) Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors. American Journal of Obstetrics and Gynecology.
Crossref
Crossref
Alexandros Velegrakis, Elisavet Kouvidi, Persefoni Fragkiadaki & Stavros Sifakis. (2023) Predictive value of the sFlt‑1/PlGF ratio in women with suspected preeclampsia: An update (Review). International Journal of Molecular Medicine 52:4.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Dustyn Levenson & Adi L. Tarca. (2023) One-third of patients with eclampsia at term do not have an abnormal angiogenic profile. Journal of Perinatal Medicine 51:5, pages 652-663.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Arthur Krieger, Piya Chaemsaithong, Offer Erez & Adi L. Tarca. (2023) Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. American Journal of Obstetrics and Gynecology 228:5, pages 569.e1-569.e24.
Crossref
Crossref
Dorota Sroka, Lisa-Antonia Lorenz-Meyer, Valerie Scherfeld, Julie Thoma, Andreas Busjahn, Wolfgang Henrich & Stefan Verlohren. (2023) Comparison of the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio Alone versus a Multi-Marker Regression Model for the Prediction of Preeclampsia-Related Adverse Outcomes after 34 Weeks of Gestation. Fetal Diagnosis and Therapy 50:3, pages 215-224.
Crossref
Crossref
A.V. Pylypenko & V.I. Medved. (2022) To the question of the clinical predictive value of the sFlt-1:PlGF ratio is related to the placental dysfunction. Reproductive health of woman:7, pages 21-29.
Crossref
Crossref
Adi L. Tarca, Roberto Romero, Gaurav Bhatti, Francesca Gotsch, Bogdan Done, Dereje W. Gudicha, Dahiana M. Gallo, Eunjung Jung, Roger Pique-Regi, Stanley M. Berry, Tinnakorn Chaiworapongsa & Nardhy Gomez-Lopez. (2022) Human Plasma Proteome During Normal Pregnancy. Journal of Proteome Research 21:11, pages 2687-2702.
Crossref
Crossref
Roberto Romero, Eunjung Jung, Tinnakorn Chaiworapongsa, Offer Erez, Dereje W. Gudicha, Yeon Mee Kim, Jung-Sun Kim, Bomi Kim, Juan Pedro Kusanovic, Francesca Gotsch, Andreea B. Taran, Bo Hyun Yoon, Sonia S. Hassan, Chaur-Dong Hsu, Piya Chaemsaithong, Nardhy Gomez-Lopez, Lami Yeo, Chong Jai Kim & Adi L. Tarca. (2022) Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology. American Journal of Obstetrics and Gynecology 227:4, pages 615.e1-615.e25.
Crossref
Crossref
Leon J. Schmidt, Oliver Rieger, Mark Neznansky, Max Hackelöer, Lisa A. Dröge, Wolfgang Henrich, David Higgins & Stefan Verlohren. (2022) A machine-learning–based algorithm improves prediction of preeclampsia-associated adverse outcomes. American Journal of Obstetrics and Gynecology 227:1, pages 77.e1-77.e30.
Crossref
Crossref
Stefan Verlohren, Shaun P. Brennecke, Alberto Galindo, S. Ananth Karumanchi, Ljiljana B. Mirkovic, Dietmar Schlembach, Holger Stepan, Manu Vatish, Harald Zeisler & Sarosh Rana. (2022) Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertension 27, pages 42-50.
Crossref
Crossref
Eunjung Jung, Roberto Romero, Lami Yeo, Nardhy Gomez-Lopez, Piya Chaemsaithong, Adithep Jaovisidha, Francesca Gotsch & Offer Erez. (2022) The etiology of preeclampsia. American Journal of Obstetrics and Gynecology 226:2, pages S844-S866.
Crossref
Crossref
Nikos A. Kametas, Diane Nzelu & Kypros H. Nicolaides. (2022) Chronic hypertension and superimposed preeclampsia: screening and diagnosis. American Journal of Obstetrics and Gynecology 226:2, pages S1182-S1195.
Crossref
Crossref
Sarosh Rana, Suzanne D. Burke & S. Ananth Karumanchi. (2022) Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. American Journal of Obstetrics and Gynecology 226:2, pages S1019-S1034.
Crossref
Crossref
Adi L. Tarca, Andreea Taran, Roberto Romero, Eunjung Jung, Carmen Paredes, Gaurav Bhatti, Corina Ghita, Tinnakorn Chaiworapongsa, Nandor Gabor Than & Chaur-Dong Hsu. (2022) Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study. American Journal of Obstetrics and Gynecology 226:1, pages 126.e1-126.e22.
Crossref
Crossref
S. Ananth Karumanchi, Sarosh Rana & Robert N. Taylor. 2022. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
165
185
.
Sean Lim, Wentao Li, Jessica Kemper, Andrew Nguyen, Ben Willem Mol & Maya Reddy. (2021) Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia. Obstetrics & Gynecology 137:1, pages 72-81.
Crossref
Crossref
Suji Kim, Minsik Park, Ji-Yoon Kim, Taesam Kim, Jong Hwang, Kwon-Soo Ha, Moo-Ho Won, Sungwoo Ryoo, Young-Guen Kwon & Young-Myeong Kim. (2020) Circulating miRNAs Associated with Dysregulated Vascular and Trophoblast Function as Target-Based Diagnostic Biomarkers for Preeclampsia. Cells 9:9, pages 2003.
Crossref
Crossref
Diane Nzelu, Dan Biris, Theodoros Karampitsakos, Kypros K. Nicolaides & Nikos A. Kametas. (2020) First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia. American Journal of Obstetrics and Gynecology 222:4, pages 374.e1-374.e9.
Crossref
Crossref
Yvonne Kwun Yue Cheng, Liona Chiu Yee Poon, Andrew Shennan, Tak Yeung Leung & Daljit Singh Sahota. (2019) Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor. Pregnancy Hypertension 17, pages 165-171.
Crossref
Crossref
Elizabeth A. Phipps, Ravi Thadhani, Thomas Benzing & S. Ananth Karumanchi. (2019) Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nature Reviews Nephrology 15:5, pages 275-289.
Crossref
Crossref
Sarosh RanaElizabeth LemoineJoey P. GrangerS. Ananth Karumanchi. (2019) Preeclampsia. Circulation Research 124:7, pages 1094-1112.
Crossref
Crossref
Ignacio Herraiz García, Elisa Llurba Olive, Alberto Galindo Izquierdo & Stefan Verlohren. (2019) Actualización del diagnóstico y el pronóstico de la preeclampsia en embarazos únicos con la ayuda del cociente sFlt-1/PlGF. Progresos de Obstetricia y Ginecología.
Crossref
Crossref
Anton A Turanov, Agnes Lo, Matthew R Hassler, Angela Makris, Ami Ashar-Patel, Julia F Alterman, Andrew H Coles, Reka A Haraszti, Loic Roux, Bruno M D C Godinho, Dimas Echeverria, Suzanne Pears, Jim Iliopoulos, Renuka Shanmugalingam, Robert Ogle, Zsuzsanna K Zsengeller, Annemarie Hennessy, S Ananth Karumanchi, Melissa J Moore & Anastasia Khvorova. (2018) RNAi modulation of placental sFLT1 for the treatment of preeclampsia. Nature Biotechnology 36:12, pages 1164-1173.
Crossref
Crossref
Sarosh Rana, Saira Salahuddin, Ariel Mueller, Anders H. Berg, Ravi I. Thadhani & S. Ananth Karumanchi. (2018) Angiogenic biomarkers in triage and risk for preeclampsia with severe features. Pregnancy Hypertension 13, pages 100-106.
Crossref
Crossref
E. Sabriá, P. Lequerica‐Fernández, P. Lafuente-Ganuza, E. Eguia-Ángeles, A. I. Escudero, E. Martínez‐Morillo, C. Barceló & F. V. Álvarez. (2018) Addition of N‐terminal pro‐B natriuretic peptide to soluble fms‐like tyrosine kinase‐1/placental growth factor ratio > 38 improves prediction of pre‐eclampsia requiring delivery within 1 week: a longitudinal cohort study. Ultrasound in Obstetrics & Gynecology 51:6, pages 758-767.
Crossref
Crossref
Kathryn J. Gray, Richa Saxena & S. Ananth Karumanchi. (2018) Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis. American Journal of Obstetrics and Gynecology 218:2, pages 211-218.
Crossref
Crossref
Yvonne Kwun Yue Cheng, Lai Wa Law, Tak Yeung Leung, Oi Ka Chan & Daljit Singh Sahota. (2018) Soluble fms-like tyrosine kinase-1, placental growth factor and their ratio as a predictor for pre-eclampsia in East Asians. Pregnancy Hypertension 11, pages 61-65.
Crossref
Crossref
Tracy E. Hunley, Neerav Desai & Deborah P. Jones. 2018. Pediatric Hypertension. Pediatric Hypertension
581
603
.
U. Vivian UkahJennifer A. HutcheonBeth PayneMatthew D. HaslamManu VatishJ. Mark AnserminoHelen BrownLaura A. MageePeter von Dadelszen. (2017) Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy. Hypertension 70:6, pages 1228-1237.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Offer Erez, Adi L. Tarca, Agustin Conde-Agudelo, Piya Chaemsaithong, Chong Jai Kim, Yeon Mee Kim, Jung-Sun Kim, Bo Hyun Yoon, Sonia S. Hassan, Lami Yeo & Steven J. Korzeniewski. (2017) The prediction of fetal death with a simple maternal blood test at 24-28 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio). American Journal of Obstetrics and Gynecology 217:6, pages 682.e1-682.e13.
Crossref
Crossref
Roberto Romero, Offer Erez, Maik Hüttemann, Eli Maymon, Bogdan Panaitescu, Agustin Conde-Agudelo, Percy Pacora, Bo Hyun Yoon & Lawrence I. Grossman. (2017) Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. American Journal of Obstetrics and Gynecology 217:3, pages 282-302.
Crossref
Crossref
A. Perales, J. L. Delgado, M. de la Calle, J. A. García-Hernández, A. I. Escudero, J. M. Campillos, M. D. Sarabia, B. Laíz, M. Duque, M. Navarro, P. Calmarza, M. Hund & F. V. Álvarez. (2017) sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain). Ultrasound in Obstetrics & Gynecology 50:3, pages 373-382.
Crossref
Crossref
Mancy Tong, Qi Chen, Joanna L. James, Peter R. Stone & Lawrence W. Chamley. (2017) Micro- and Nano-vesicles from First Trimester Human Placentae Carry Flt-1 and Levels Are Increased in Severe Preeclampsia. Frontiers in Endocrinology 8.
Crossref
Crossref
Roberto Romero, Offer Erez, Eli Maymon, Piya Chaemsaithong, Zhonghui Xu, Percy Pacora, Tinnakorn Chaiworapongsa, Bogdan Done, Sonia S. Hassan & Adi L. Tarca. (2017) The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study. American Journal of Obstetrics and Gynecology 217:1, pages 67.e1-67.e21.
Crossref
Crossref
S.A. Karumanchi. 2017. Biomarkers of Kidney Disease. Biomarkers of Kidney Disease
555
594
.
Tracy E. Hunley, Neerav Desai & Deborah P. Jones. 2017. Pediatric Hypertension. Pediatric Hypertension
1
23
.
Indira Álvarez-Fernández, Belén Prieto, Verónica Rodríguez, Yolanda Ruano, Ana I. Escudero & Francisco V. Álvarez. (2016) N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia. Clinica Chimica Acta 463, pages 150-157.
Crossref
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Crossref
Kedak Baltajian, Surichhya Bajracharya, Saira Salahuddin, Anders H. Berg, Carl Geahchan, Julia B. Wenger, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2016) Sequential plasma angiogenic factors levels in women with suspected preeclampsia. American Journal of Obstetrics and Gynecology 215:1, pages 89.e1-89.e10.
Crossref
Crossref
S. Ananth Karumanchi. (2016) Angiogenic Factors in Preeclampsia. Hypertension 67:6, pages 1072-1079.
Crossref
Crossref
Steven J. Korzeniewski, Roberto Romero, Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Chong Jai Kim, Yeon Mee Kim, Jung-Sun Kim, Bo Hyun Yoon, Sonia S. Hassan & Lami Yeo. (2016) Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. American Journal of Obstetrics and Gynecology 214:5, pages 629.e1-629.e17.
Crossref
Crossref
Harald Zeisler, Elisa Llurba, Frederic Chantraine, Manu Vatish, Anne Cathrine Staff, Maria Sennström, Matts Olovsson, Shaun P. Brennecke, Holger Stepan, Deirdre Allegranza, Peter Dilba, Maria Schoedl, Martin Hund & Stefan Verlohren. (2016) Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. New England Journal of Medicine 374:1, pages 13-22.
Crossref
Crossref
Mary Putt, Virginia Shalkey Hahn, James L Januzzi, Heloisa Sawaya, Igal A Sebag, Juan Carlos Plana, Michael H Picard, Joseph R Carver, Elkan F Halpern, Irene Kuter, Jonathan Passeri, Victor Cohen, Jose Banchs, Randolph P Martin, Robert E Gerszten, Marielle Scherrer-Crosbie & Bonnie Ky. (2015) Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab. Clinical Chemistry 61:9, pages 1164-1172.
Crossref
Crossref
Ignacio Herraiz, Elisa Simón, Paula Gómez-Arriaga, José Martínez-Moratalla, Antonio García-Burguillo, Elena Jiménez & Alberto Galindo. (2015) Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration. International Journal of Molecular Sciences 16:8, pages 19009-19026.
Crossref
Crossref
L.R. Leffert. (2015) What’s new in obstetric anesthesia? Focus on preeclampsia. International Journal of Obstetric Anesthesia 24:3, pages 264-271.
Crossref
Crossref
Eun Na Kim, Bo Hyun Yoon, Joong Yeup Lee, Doyeong Hwang, Ki Chul Kim, JoonHo Lee, Jae-Yoon Shim & Chong Jai Kim. (2015) Placental C4d deposition is a feature of defective placentation: observations in cases of preeclampsia and miscarriage. Virchows Archiv 466:6, pages 717-725.
Crossref
Crossref
Glenn E. Palomaki, James E. Haddow, Hamish R. M. Haddow, Saira Salahuddin, Carl Geahchan, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Gary Horowitz, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2015) Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenatal Diagnosis 35:4, pages 386-393.
Crossref
Crossref
Monica Sircar, Ravi Thadhani & S. Ananth Karumanchi. (2015) Pathogenesis of preeclampsia. Current Opinion in Nephrology and Hypertension 24:2, pages 131-138.
Crossref
Crossref
H. Stepan, I. Herraiz, D. Schlembach, S. Verlohren, S. Brennecke, F. Chantraine, E. Klein, O. Lapaire, E. Llurba, A. Ramoni, M. Vatish, D. Wertaschnigg & A. Galindo. (2015)
Implementation of the
sFlt
‐1/
PlGF
ratio for prediction and diagnosis of pre‐eclampsia in singleton pregnancy: implications for clinical practice
. Ultrasound in Obstetrics & Gynecology 45:3, pages 241-246.
Crossref
Crossref
Juha Rasanen, Matthew J. Quinn, Amber Laurie, Eric Bean, Charles T. RobertsJr.Jr., Srinivasa R. Nagalla & Michael G. Gravett. (2015) Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia. American Journal of Obstetrics and Gynecology 212:1, pages 82.e1-82.e9.
Crossref
Crossref
S. Ananth Karumanchi, Sarosh Rana & Robert N. Taylor. 2015. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
113
132
.
Martin Hund, Deirdre Allegranza, Maria Schoedl, Peter Dilba, Wilma Verhagen-Kamerbeek & Holger Stepan. (2014) Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy and Childbirth 14:1.
Crossref
Crossref
Nandini Raghuraman, Melissa I. March, Michele R. Hacker, Anna Merport Modest, Julia Wenger, Rulx Narcisse, Jean Louis David, Jennifer Scott & Sarosh Rana. (2014) Adverse maternal and fetal outcomes and deaths related to preeclampsia and eclampsia in Haiti. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 4:4, pages 279-286.
Crossref
Crossref
Attila Molvarec, Nóra Gullai, Balázs Stenczer, Gergely Fügedi, Bálint Nagy & János Rigó Jr. (2013) Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study. BMC Pregnancy and Childbirth 13:1.
Crossref
Crossref